EPIcol
Unknown
180 enrolled
Hepatobiliary Tumors Tissue Samples Acquisition
Unknown
450 enrolled
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.
Unknown
52 enrolled
IMMUNOREACT2
Unknown
544 enrolled
The Association Between Calretinin and the Function of Ganglion Cells in Hirschsprung Disease
Unknown
50 enrolled
Fibrotic Focus in Breast Cancer
Unknown
250 enrolled
SUCCESS
Unknown
30 enrolled
Prognostic Value of PD-L1 in NSCLC
Unknown
350 enrolled
Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study
Unknown
40 enrolled
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
Unknown
Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)
Unknown
55 enrolled
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial
Unknown
1,874 enrolled
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
Unknown
1,800 enrolled
Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer
Unknown
120 enrolled
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Unknown
60 enrolled
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
Unknown
300 enrolled
Study of Families With Melanoma
Unknown
3,700 enrolled
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
Unknown
1,000 enrolled
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
Unknown
957 enrolled
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Unknown
1,000 enrolled
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
Unknown
865 enrolled
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
Unknown
513 enrolled